- Home
- FMN vs SERA Comparison
FMN vs SERA Comparison
Compare FMN & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMN
- SERA
- Stock Information
- Founded
- FMN 2002
- SERA 2008
- Country
- FMN United States
- SERA United States
- Employees
- FMN N/A
- SERA N/A
- Industry
- FMN Investment Managers
- SERA Precision Instruments
- Sector
- FMN Finance
- SERA Health Care
- Exchange
- FMN Nasdaq
- SERA Nasdaq
- Market Cap
- FMN 82.6M
- SERA 70.4M
- IPO Year
- FMN N/A
- SERA 2021
- Fundamental
- Price
- FMN $10.64
- SERA $2.49
- Analyst Decision
- FMN
- SERA
- Analyst Count
- FMN 0
- SERA 0
- Target Price
- FMN N/A
- SERA N/A
- AVG Volume (30 Days)
- FMN 22.8K
- SERA 806.3K
- Earning Date
- FMN 01-01-0001
- SERA 08-06-2025
- Dividend Yield
- FMN 3.86%
- SERA N/A
- EPS Growth
- FMN N/A
- SERA N/A
- EPS
- FMN N/A
- SERA N/A
- Revenue
- FMN N/A
- SERA $115,000.00
- Revenue This Year
- FMN N/A
- SERA $390.13
- Revenue Next Year
- FMN N/A
- SERA $440.54
- P/E Ratio
- FMN N/A
- SERA N/A
- Revenue Growth
- FMN N/A
- SERA N/A
- 52 Week Low
- FMN $9.09
- SERA $1.37
- 52 Week High
- FMN $11.31
- SERA $9.13
- Technical
- Relative Strength Index (RSI)
- FMN 51.46
- SERA 53.89
- Support Level
- FMN $10.55
- SERA $1.82
- Resistance Level
- FMN $10.77
- SERA $4.09
- Average True Range (ATR)
- FMN 0.09
- SERA 0.36
- MACD
- FMN 0.01
- SERA 0.10
- Stochastic Oscillator
- FMN 40.91
- SERA 35.74
About FMN Federated Hermes Premier Municipal Income Fund
Federated Hermes Premier Municipal Income Fund is a United States-based diversified, closed-end management investment company. The investment objective of the fund is to provide current income exempt from federal income tax, including the federal alternative minimum tax by investing in long-term, tax exempt municipal bonds diversified among states, sectors and issuers. Its portfolio of investments comprises different sectors such as hospitals, toll road, senior care, airport, tobacco, and other sectors.
About SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.